| Literature DB >> 26830811 |
Tianjiao Wang1, Jing Yan1, Wei Xu1, Qinghui Ai1, Kangsen Mai1.
Abstract
The present study was conducted to investigate the effects of a high-lipid diet (HLD) on cyclooxygenase (Cox)-2 expression and the signalling pathways related to low-grade inflammation in the large yellow croaker (Larmichthys crocea). An isolated 2508 bp cDNA clone of cox-2 contained an open reading frame spanning 1827 bp encoding a protein with 608 amino acid residues. The over-expression of cox-2 was consistent with the activation of c-Jun N-terminal kinases (JNKs) and p38 mitogen-activated protein kinase (MAPK) in HLD-fed fish. The activation of the activator protein-1 (AP-1) and the nuclear transcription factor kappa-B (NF-κB) signalling pathways in HLD-fed fish and the significant increase of cox-2 promoter-luciferase activity in vitro indicated that AP-1 and NF-κB could combine cox-2 promoter to promote its transcription, respectively. Together, HLD-induced inflammation up-regulates cox-2 expression via JNKs and p38 MAPK-dependent NF-κB and AP-1 pathways. The present study provides important insight into the signal transduction pathways involved in HLD-induced inflammation, which is detrimental to the health and production of fish as well as to the health of fish consumers.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26830811 PMCID: PMC4735279 DOI: 10.1038/srep19921
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Nucleotide and deduced amino acid sequences of cox-2.
The deduced amino acid sequences are shown below the cDNA sequences. The initiation codon (ATG) and the stop codon were characterized in bold.
Figure 2Multiple sequence alignment of Cox-2 and other invertebrate Cox-2.
Alignment was performed using ClustalW2. Identical residues are indicated in black, and similar residues in light gray. Dashes indicate gaps. Identities are shown as black boxes and shaded boxes represent similar amino acids.
Figure 3Phylogenetic tree of Cox-2.
The phylogenetic tree was constructed using MEGA 4.0 software by the Neighbor-joining method based on sequence alignment using ClustalW2 and 1000 replications of bootstrap. The scale bar indicated a branch length of 0.2. Amino acid sequences of Cox-2 are obtained from invertebrate and vertebrate animals.
Figure 4Tissue distribution of cox-2 in large yellow croaker.
Relative cox-2 mRNA expression was determined by quantitative realtime PCR (qRT-PCR) and expressed relative to β-actin levels. Results are expressed as means ± S.E.M. (n = 3). Different letters above the bars denote significant differences among tissues at the P < 0.05 level (P = 0.000) as determined by one-way ANOVA followed by Tukey’s test (SPSS).
Figure 5Relative cox-2, TNFα and IL-1β mRNA levels.
Relative cox-2, TNFα and IL-1β mRNA levels were evaluated by quantitative realtime PCR (qRT-PCR) and expressed relative to β-actin levels in the liver of experimental fish. Results are expressed as means ± S.E.M. (n = 3). *P < 0.05, **P < 0.01.
Figure 6The Cox-2 protein expression levels.
The Cox-2 protein expression levels were evaluated by Western blot and expressed relative to β-actin levels in the liver of experimental fish. Data are expressed as A.U. of the Western blots and are depicted as a ratio of Cox-2 to β-actin, (n = 3 in each group). All data are presented as mean ± S.E.M. *P < 0.05, **P < 0.01.
Figure 7HLD activates the phosphorylation of JNK1/2 and p38 MAPK but not ERK1/2.
Quantitative results of p-ERK1/2, p-JNK1/2 and p-p38 protein levels, which were adjusted with the total ERK1/2, p38, and JNK1/2 protein levels in the liver of experimental fish were analysed using Western blot. Data are expressed as A.U. of the Western blots and are depicted as a ratio of p-ERK1/2 (pThr202/Tyr204) to total ERK1/2, p-JNK1/2 (pThr183/Thr185) to total JNK1/2, and p-p38 (pThr180/Thr182) to total p38 (n = 3 in each group). All data are presented as mean ± S.E.M. *P < 0.05, **P < 0.01.
Figure 8HLD activates the NF-κB and AP-1 pathway.
Quantitative results of p-c-Jun, p-IKKα/β, p-IκBα protein levels, which were adjusted with the total c-Jun, IKKα/β and IκBα protein levels, were analysed using Western blot. Nuclear NF-κB p65 protein levels which were adjusted with the total NF-κB p65 protein levels, were also analysed using Western blot in the liver of experimental fish. Data are expressed as A.U. of the Western blots and are depicted as a ratio of p-c-Jun (pSer73) to total c-Jun, p-IKKα/β (pSer176/Ser180) to total IKKα/β, p-IκBα (pSer32/Ser36) to total IκBα and nuclear-NF-κB p65 to total NF-κB (n = 3 in each group). All data are presented as mean ± S.E.M. *P < 0.05, **P < 0.01.
Figure 9Relative dual-luciferase activity analysis of NF-κB and AP-1 in the cox-2 promoter in HEK293 cells.
The bars indicated relative luciferase activity (n = 3). PRL-CMV and pGL3-Basic used as control. The amount relative to the internal control is expressed as mean ± S.E.M. (n = 3). Significant differences across control were indicated.
Formulation and proximate composition of the experimental diets.
| Dietary lipid levels (%) | ||
|---|---|---|
| CON (12) | HLD (18) | |
| Ingredients (g/100 g) | ||
| Fish meal | 39.00 | 39.00 |
| Soybean meal | 20.00 | 20.00 |
| Wheat meal | 23.30 | 23.30 |
| Wheat starch | 6.00 | 0.00 |
| Fish oil | 6.00 | 12.00 |
| Soybean lecithin | 1.50 | 1.50 |
| Vitamin premix | 2.00 | 2.00 |
| Mineral premix | 2.00 | 2.00 |
| Attractant | 0.10 | 0.10 |
| Mold inhibitor | 0.10 | 0.10 |
| Proximate composition (g/100 g) | ||
| Moisture | 9.40 | 9.20 |
| Crude protein | 42.60 | 43.20 |
| Crude lipid | 11.50 | 17.80 |
1Fish meal: crude protein 74.3% dry matter, crude lipid 6.6% dry matter; soybean meal: crude protein 49.4% dry matter, crude lipid 0.9% dry matter; wheat meal: crude protein 16.4% dry matter, crude lipid 1.0% dry matter; All of these ingredients were supplied by Great Seven Biotechnology Co., Ltd., China.
2Fish oil: palmitic acid (16:0) content, 15.77% total fatty acids (TFA); oleic acid (18:1n-9) content, 3.29% TFA; linoleic acid (18:2n-6) content: 2.12% TFA; alpha-linolenic acid (18:3n-3) content: 0.42% TFA; ARA content, 0.23% TFA; EPA content, 13.34% TFA; DHA content, 10.53% TFA, bought from the Great Seven Biotechnology Co, Ltd, Qingdao, China
3Soybean lecithin: palmitic acid (16:0) content, 16. 5% TFA, stearic acid (18:0) content, 4.2% TFA, oleic acid (18:1n-9) content, 12.1% TFA, linoleic acid (18:2n-6) content: 59.2% TFA, supplied by Liuhe Feed Co., Ltd.
4Vitamin premix (mg or g/kg diet): cholecalciferol, 5 mg; retinol acetate, 32 mg; thiamin 25 mg;vitamin B12 (1%), 10 mg; riboflavin, 45 mg; pyridoxine HCl, 20 mg; ascorbic acid, 2000 mg; alpha-tocopherol (50%), 240 mg; vitamin K3, 10 mg; pantothenic acid, 60 mg; inositol, 800 mg; niacin acid, 200 mg; folic acid, 20 mg; biotin (2%), 60 mg; choline chloride (50%), 4000 mg;microcrystalline cellulose, 12.47 g.
5Mineral premix (mg or g/kg diet): CuSO4·5H2O, 10 mg; Ca (IO3)2·6H2O (1%), 60 mg; CoCl2·6H2O (1%), 50 mg; FeSO4·H2O, 80 mg; MgSO4·7H2O, 1200 mg; MnSO4·H2O, 45 mg; NaSeSO3·5H2O (1%), 20 mg; ZnSO4·H2O, 50 mg; CaH2PO4·H2O, 10 g; zeolite, 8.485 g.
6Attractants: glycine and betaine.
7Mold inhibitor: contained 50% calcium propionic acid and 50% fumaric acid.
Fatty acid composition of the experimental diets (% total fatty acids).
| Fatty acid | Dietary lipid level(%) | |
|---|---|---|
| CON(12) | HLD(18) | |
| C14:0 | 6.17 | 6.17 |
| C16:0 | 20.43 | 19.52 |
| C18:0 | 2.92 | 2.51 |
| C20:0 | 1.72 | 2.26 |
| ∑SFA | 31.23 | 30.46 |
| C16:1 | 8.83 | 8.68 |
| C18:1n | 19.18 | 22.31 |
| C22:1n-9 | 1.21 | 1.75 |
| ∑MUFA | 29.22 | 32.74 |
| C18:2n-6 | 12.53 | 9.86 |
| C18:3n-6 | 1.43 | 1.46 |
| ARA | 0.71 | 0.65 |
| ∑n-6PUFA | 14.67 | 11.97 |
| C18:3n-3 | 1.86 | 1.71 |
| C18:4n-3 | 0.31 | 0.39 |
| C20:5n-3 | 9.19 | 8.25 |
| C22:6n-3 | 8.46 | 8.68 |
| ∑n-3PUFA | 2.17 | 2.10 |
| n-3/n-6PUFA | 0.15 | 0.18 |
| ∑n-3 LC-PUFA | 17.65 | 16.93 |
| DHA/EPA | 0.92 | 1.05 |
1SFAs: saturated fatty acids.
2MUFAs: mono-unsaturated fatty acids.
3n−6 PUFAs: n−6 polyunsaturated fatty acids.
4n−3 PUFAs: n−3 polyunsaturated fatty acids.
5n−3 LC-PUFAs: n−3 long chain polyunsaturated fatty acids.
6DHA/EPA: 22:6n−3/20:5n−3.
Sequences of the primers used in this study.
| Primers | Sequence(5′-3′) |
|---|---|
| For clone | |
| Cox-2-F | CACCCACCAGTTCTTCAAATCTG |
| Cox-2-R | TGGTACAGGGTGTTGAACTCGG |
| Cox-2-3′F1 | ACAACCTGGAAAGGCAACACAAGCT |
| Cox-2-3′F2 | TGACTGGGATGACGAAAGGCTCT |
| Cox-2-5′R1 | CGTGTGGTCTGGAAGAGCCTTTCGTCAT |
| Cox-2-5′R2 | AGCCTCGTGACCCACAGCGAAGCGG |
| Universal Primer A Mix (UPM) | CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT |
| Nest Universal Primer (NUP) | CTAATACGACTCACTATAGGGC |
| For qRT-PCR | |
| Cox-2-RT-F | CTGGAAAGGCAACACAAGC |
| Cox-2-RT-R | CGGTGAGAGTCAGGGACAT |
| TNFα-RT-F | ACACCTCTCAGCCACAGGAT |
| TNFα-RT-R | CCGTGTCCCACTCCATAGTT |
| IL-1β-RT-F | CAATCTGGCAAGGATCAGC |
| IL-1β-RT-R | GGACGGACACAAGGGTACTAA |
| β-actin-F | TTATGAAGGCTATGCCCTGCC |
| β-actin-R | TGAAGGAGTAGCCACGCTCTGT |
| For construction of plasmidsa | |
| pCS-p65-EcoRI | CGGAATTCATGGCGGATGTGT |
| pCS-p65-Xhol | CCGCTCGAGTCATACGGACG |
| pCS-c-Jun-EcoRI | CCGGAATTCATGTATACCAAGATGG |
| pCS-c-Jun-Xhol | CCGCTCGAGTCAGAAGGTCTGGAG |
| pGL3-Cox-2-KpnI | GGGGTACCTAACAAAGACAATTCACAGG |
| pGL3-Cox-2-Xhol | CCGCTCGAGACTCCAAAGACTTTGTC |